Treatment of Androgenetic Alopecia with Autologous CD200 Positive Cell Suspension
January 2023
in “
Turk Dermatoloji Dergisi
”
Studysummary In a single case study, researchers reported increased hair density using a trypsin-isolated cell suspension containing CD34 and CD200 positive cells for treating grade III androgenetic alopecia.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer